SIGA Technologies Inc SIGA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:32 AM EDT
6.85quote price arrow down-0.10 (-1.44%)
Volume
16,130
52 week range
5.25 - 8.10

...

Loading . . .
  • Open6.87
  • Day High6.88
  • Day Low6.80
  • Prev Close6.95
  • 52 Week High8.10
  • 52 Week High Date08/10/20
  • 52 Week Low5.25
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap521.08M
  • Shares Out76.07M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.88
  • YTD % Change-4.4

KEY STATS

  • Open6.87
  • Day High6.88
  • Day Low6.80
  • Prev Close6.95
  • 52 Week High8.10
  • 52 Week High Date08/10/20
  • 52 Week Low5.25
  • 52 Week Low Date05/14/20
  • Market Cap521.08M
  • Shares Out76.07M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.88
  • YTD % Change-4.4

RATIOS/PROFITABILITY

  • EPS (TTM)0.82
  • P/E (TTM)8.37
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)87.04M
  • ROE (MRQ)61.12%
  • Revenue (MRQ)127.15M
  • Gross Margin (MRQ)88.25%
  • Net Margin (MRQ)50.67%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SIGA Technologies Inc

There is no recent news for this security.

Profile

MORE
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on health security market. The Company’s lead product TPOXX is approved by the Unites States Food and Drug Administration (FDA) as a drug with an indication for treatment of smallpox. TPOXX is an oral formulation, which is also known as tecovirimat and ST-246. The Company is developing the intravenous (IV) formulation for patients who are unable to swallow oral capsules. It is also focused on...
Eric Rose M.D.
Chairman
Phillip Gomez III
Chief Executive Officer
Daniel Luckshire
Chief Financial Officer
Dennis Hruby Ph.D.
Vice President
Address
31 E 62nd St
New York, NY
10065-8014
United States

Top Peers

SYMBOLLASTCHG%CHG
RLMD
Relmada Therapeutics Inc
34.16-0.41-1.19%
AVDL
Avadel Pharmaceuticals PLC
8.00-0.08-0.99%
SPPI
Spectrum Pharmaceuticals Inc
3.00-0.07-2.28%
SEEL
Seelos Therapeutics Inc
4.64-0.21-4.33%
CDXC
Chromadex Corp
6.91-0.25-3.49%